<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJEMD</journal-id><journal-title-group><journal-title>Open Journal of Endocrine and Metabolic Diseases</journal-title></journal-title-group><issn pub-type="epub">2165-7424</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojemd.2015.55007</article-id><article-id pub-id-type="publisher-id">OJEMD-56760</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  From Russia with Polyuria
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>aLim</surname><given-names>Ki</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Udaya</surname><given-names>M. Kabadi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Veterans Affairs Medical Center, Des Moines, Iowa, USA</addr-line></aff><aff id="aff1"><addr-line>Des Moines University, Des Moines, Iowa, USA</addr-line></aff><pub-date pub-type="epub"><day>27</day><month>05</month><year>2015</year></pub-date><volume>05</volume><issue>05</issue><fpage>51</fpage><lpage>53</lpage><history><date date-type="received"><day>18</day>	<month>May</month>	<year>2015</year></date><date date-type="rev-recd"><day>accepted</day>	<month>25</month>	<year>May</year>	</date><date date-type="accepted"><day>28</day>	<month>May</month>	<year>2015</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: Polyuria is a sign for many disease processes, including diabetes mellitus and diabetes insipidus. Urine osmolarity helps distinguish osmotic diuresis caused by diabetes mellitus from water dieresis induced by diabetes insipidus. Case Presentation: We report a case of a 48-year-old woman who presented with polyuria, polydipsia, nocturia, and weight loss after a return from a visit to Russia, during which she received a five-day course of antibiotic Demeclocycline, a tetracycline derivative for dental treatment. She recovered from all clinical manifestations by 8 weeks. Conclusion: Manifestation of transient nephrogenic diabetes insipidus is induced by Demeclocycline.
 
</p></abstract><kwd-group><kwd>Polyuria</kwd><kwd> Urine Osmolarity</kwd><kwd> Nephrogenic Diabetes Insipidus</kwd><kwd> Demeclocycline</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Polyuria, urine production of more than 3 L/d, results from excretion of non-absorbable solutes (osmotic diuresis) or over-excretion of water (water diuresis) [<xref ref-type="bibr" rid="scirp.56760-ref1">1</xref>] . Osmotic diuresis ensues due to elevated urine osmolality usual- ly &gt;300 mosm/l on collection of large amounts of solutes in the renal tubules, major solutes being glucose in diabetes mellitus and mannitol and radiocontrast media administered exogenously [<xref ref-type="bibr" rid="scirp.56760-ref1">1</xref>] . In contrast, water diuresis occurs secondary to central diabetes insipidus caused by inadequate secretion of antidiuretic hormone (ADH) or nephrogenic diabetes insipidus due to failure of renal tubules to respond to circulating ADH with excretion of extremely dilute urine with osmolality &lt; 250 mosm [<xref ref-type="bibr" rid="scirp.56760-ref1">1</xref>] . In this report, we describe a rare occurrence of nephrogenic diabetes insipidus triggered by administration of antibiotic, demeclocyline.</p></sec><sec id="s2"><title>2. Case Presentation</title><p>Forty eight year old woman was referred to endocrine clinic for polyuria and nocturia several times a day as well as polydipsia and 5 - 6 kg weight loss, vague abdominal pain, dry mouth, and tongue turning black and furry over two weeks’ duration. She denied chest pain, heart racing, heat/cold intolerance, diaphoresis, shortness of breath, nausea, vomiting, diarrhea, headache, and visual changes. She denied recent head trauma One week prior to the onset of symptoms, she had undergone a tooth implant in Russia and was given a five day prophylactic antibiotic course. Her past medical and surgical histories were unremarkable. She is a non-smoker and did not use alcohol, illicit drugs, or over-the-counter herbals or supplements and has no known allergies. Family history was non-contributory.</p><p>Physical examination showed blood pressure, 116/72 mmHg; pulse rate, 68/min; respiratory rate, 12/min; body temperature, 98˚C; and weight, 62 kg. She was alert and oriented, and in no acute distress. The rest of the exam was unremarkable. Urine specific gravity was extremely low, 1.001 at this visit. Therefore, she was asked not to drink any fluids starting 7:00 pm that day and return following morning for further laboratory testing including “water deprivation test”. At the follow up encounter at 4 weeks, the patient was free from all clinical manifestation including polyuria, polydypsia as well as black furry tongue and all the laboratory tests were repeated.</p><p>Complete blood count, liver enzymes, free T<sub>4</sub> and thyroid stimulating hormone were normal at both visits. Pertinent metabolic panel data reveal hypokalemia and metabolic alkalosis indicative of dehydration at initial visit with restoration of hydrated status at visit 2 as reflected by lower serum creatinine, urea nitrogen and resolution of hypokalemia and metabolic alkalosis (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Results from water deprivation tests demonstrate presence of nephrogenic diabetes insipidus as documented by low urine osmolality with elevated serum ADH levels and lack of rise in urine osmolality on administration DDAVP at initial visit (<xref ref-type="table" rid="table2">Table 2</xref>) with remission at visit 2 confirmed by normalization of urine osmolality and serum ADH concentrations (<xref ref-type="table" rid="table3">Table 3</xref>). Changes in plasma renin and aldosterone concentrations confirm the presence of dehydration at initial visit and adequate hydrated state at visit 2 (<xref ref-type="table" rid="table2">Table 2</xref> and <xref ref-type="table" rid="table3">Table 3</xref>). The subject has remained free of the symptoms on 2 subsequent visits at 3 and 6 months.</p></sec><sec id="s3"><title>3. Discussion</title><p>We report a rare case of polyuria secondary to nephrogenic diabetes insipidus induced by a broad-spectrum tetracycline antibiotic, Demeclocycline prescribed prophylactically following a dental procedure by the dentist during a visit to Russia. Complete recovery of clinical manifestations following normalization of both serum ADH concentration and its effect on urine osmolality during repeated water deprivation test confirms the transient and reversible nature of the disorder on discontinuation of Demeclocycline. Our observation is consistent with the data in the literature [<xref ref-type="bibr" rid="scirp.56760-ref2">2</xref>] - [<xref ref-type="bibr" rid="scirp.56760-ref6">6</xref>] . Moreover, occurrence of black furry tongue on administration and its remission following discontinuation of Demeclocycline noted in our patient is also previously documented [<xref ref-type="bibr" rid="scirp.56760-ref6">6</xref>] .</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Pertinent metabolic panel results</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Metabolic panel normal range</th><th align="center" valign="middle" >Visit 1</th><th align="center" valign="middle" >Visit 2</th></tr></thead><tr><td align="center" valign="middle" >Serum urea nitrogen 5 - 20 mg/dl</td><td align="center" valign="middle" >21.0</td><td align="center" valign="middle" >12.0</td></tr><tr><td align="center" valign="middle" >Serum creatinine 0.6 - 1.2 mg/dl</td><td align="center" valign="middle" >0.9</td><td align="center" valign="middle" >0.6</td></tr><tr><td align="center" valign="middle" >Serum glucose 60 - 99 mg/dl</td><td align="center" valign="middle" >89</td><td align="center" valign="middle" >92</td></tr><tr><td align="center" valign="middle" >Serum sodium (Na<sup>+</sup>) 135 - 145 mosm/l</td><td align="center" valign="middle" >140</td><td align="center" valign="middle" >140</td></tr><tr><td align="center" valign="middle" >Serum potassium (K<sup>+</sup>) 3.5 - 5.0 mosm/l</td><td align="center" valign="middle" >3.3</td><td align="center" valign="middle" >4.1</td></tr><tr><td align="center" valign="middle" >Serum chloride (Cl<sup>−</sup>) 95 - 110 mosm/l</td><td align="center" valign="middle" >101</td><td align="center" valign="middle" >104</td></tr><tr><td align="center" valign="middle" >Serum bicarbonate (<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1980169x6.png" xlink:type="simple"/></inline-formula>) 25 - 32 mosm/l</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >25</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Water deprivation test at initial visit</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Time (hr)</th><th align="center" valign="middle" >Serum osmolality mosm/l (285 - 295)<sup>*</sup></th><th align="center" valign="middle" >Urine osmolality mosm/l (50 - 1100)<sup>*</sup></th><th align="center" valign="middle" >Urine specific gravity (1003 - 1030)<sup>*</sup></th><th align="center" valign="middle" >ADH pg/ml (1 - 5)<sup>*</sup></th><th align="center" valign="middle" >Renin supine ng/ml/hr (0.2 - 2.3)<sup>*</sup></th><th align="center" valign="middle" >Aldosterone supine ng/dl (3 - 10)<sup>*</sup></th></tr></thead><tr><td align="center" valign="middle" >0</td><td align="center" valign="middle" >302</td><td align="center" valign="middle" >258</td><td align="center" valign="middle" >1.003</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >4.56</td><td align="center" valign="middle" >16</td></tr><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >306</td><td align="center" valign="middle" >260</td><td align="center" valign="middle" >1.003</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >305</td><td align="center" valign="middle" >252</td><td align="center" valign="middle" >1.004</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >308</td><td align="center" valign="middle" >258</td><td align="center" valign="middle" >1.002</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >307</td><td align="center" valign="middle" >250</td><td align="center" valign="middle" >1.003</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >310</td><td align="center" valign="middle" >253</td><td align="center" valign="middle" >1.002</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p><sup>*</sup>Normal range.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Water deprivation test at visit 2<sup>*</sup></title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Time (hr)</th><th align="center" valign="middle" >Serum osmolality mosm/l</th><th align="center" valign="middle" >Serum osmolality mosm/l</th><th align="center" valign="middle" >Urine specific gravity</th><th align="center" valign="middle" >ADH pg/ml</th><th align="center" valign="middle" >Renin supine ng/ml/hr</th><th align="center" valign="middle" >Aldosterone supine ng/dl</th></tr></thead><tr><td align="center" valign="middle" >0</td><td align="center" valign="middle" >242</td><td align="center" valign="middle" >463</td><td align="center" valign="middle" >1.015</td><td align="center" valign="middle" >1.1</td><td align="center" valign="middle" >0.66</td><td align="center" valign="middle" >6</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >244</td><td align="center" valign="middle" >873</td><td align="center" valign="middle" >1.021</td><td align="center" valign="middle" >2.0</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >247</td><td align="center" valign="middle" >909</td><td align="center" valign="middle" >1.026</td><td align="center" valign="middle" >3.9</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >247</td><td align="center" valign="middle" >914</td><td align="center" valign="middle" >1.026</td><td align="center" valign="middle" >6.8</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p><sup>*</sup>Normal ranges shown in <xref ref-type="table" rid="table2">Table 2</xref>.</p><p><sup>*</sup>Corresponding author.</p></sec><sec id="s4"><title>4. Conclusion</title><p>Nephrogenic diabetes insipidus is an uncommon side effect of Demeclocycline use. There are limited reports of this finding, especially since the use of this drug has been largely replaced by other antibiotics. However, there are still areas around the world where this antibiotic is still being used. This case report suggests that Demeclocycline should be used with caution for renal failure and nephrogenic diabetes insipidus.</p></sec><sec id="s5"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.56760-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Zietse, R., Zoutendijk, R. and Hoorn, E.J. (2009) Fluid, Electrolyte and Acid-Base Disorders Associated with Antibiotic Therapy. Nature Reviews Nephrology, 5, 193-202. http://dx.doi.org/10.1038/nrneph.2009.17</mixed-citation></ref><ref id="scirp.56760-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Singer, I. and Rotenberg, D. (1973) Demeclocycline-Induced Nephrogenic Diabetes Insipidus. In-Vivo and In-Vitro Studies. Annals of Internal Medicine, 79, 679-683. http://dx.doi.org/10.7326/0003-4819-79-5-679</mixed-citation></ref><ref id="scirp.56760-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">London, A.L., Siegel, N.J., Zelson, J.H. and Hayslett, J.P. (1978) Nephrogenic Diabetes Insipidus Due to Demethylchlortetracycline Hydrochloride in a Child. Pediatrics, 61, 91-3.</mixed-citation></ref><ref id="scirp.56760-ref4"><label>4</label><mixed-citation publication-type="book" xlink:type="simple">Lin, J. and Denker, B.M. (2012) Chapter 44. Azotemia and Urinary Abnormalities. In: Longo, D.L., Fauci, A.S., Kasper, D.L., Hauser, S.L., Jameson, J. and Loscalzo, J., Eds., Harrison’s Principles of Internal Medicine, McGraw-Hill, New York, 18e.</mixed-citation></ref><ref id="scirp.56760-ref5"><label>5</label><mixed-citation publication-type="book" xlink:type="simple">Ives, H.E. (2012) Chapter 15. Diuretic Agents. In: Katzung, B.G., Masters, S.B. and Trevor, A.J., Eds., Basic &amp; Clinical Pharmacology, McGraw-Hill, New York, 12e.</mixed-citation></ref><ref id="scirp.56760-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">(2010) Demeclocycline. MedlinePlus website, updated September.  
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682103.html</mixed-citation></ref></ref-list></back></article>